Mr. Justin Hanka reports

MINDBIO HIRES SENERGY COMMUNICATIONS CAPITAL

Mindbio Therapeutics Corp. has engaged Senergy Communications Capital Inc. to provide marketing and investor awareness services.

Senergy is an arm's-length marketing, advertising and shareholder relations firm based in Vancouver, Canada. Senergy will design and execute comprehensive campaigns that include corporate branding, social media, and targeted e-mail marketing and on-line advertising and advertorial initiatives. Under the terms of the engagement, the company will pay Senergy $150,000, to cover service fees and advertising expenses, in advance for an initial three-month term commencing on Jan. 5, 2026, with the option to renew. To the company's knowledge, neither Senergy, not its principal Aleem Fidai, own any securities of the company.

About Mindbio Therapeutics Corp.

Mindbio Therapeutics is a clinical-stage biotechnology company headquartered in Vancouver, B.C., that for several years has been conducting clinical trials and is focused on developing novel treatments for mental health disorders and health prediction technologies using AI and machine learning. The company has expertise in developing speech analytics as a prediction tool for drug and alcohol intoxication.

We seek Safe Harbor.